MN-166 Publications Search results

2018.08.30 Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

2010.03.30 Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?

2010.03.30 Primary neuroprotection: the Holy Grail of multiple sclerosis therapy

2004.03.01 Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia

2003.12.09 Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development

1999.08.07 Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS

1998.06.01 Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity

1996.06.01 Ibudilast protects against neuronal damage induced by glutamate in cultured hippocampal neurons